A256940 logo

Keeps Biopharma Stock Price

Symbol: KOSDAQ:A256940Market Cap: ₩245.9bCategory: Semiconductors

A256940 Share Price Performance

₩12,890.00
7770.00 (151.76%)
₩12,890.00
7770.00 (151.76%)
Price ₩12,890.00

A256940 Community Narratives

There are no narratives available yet.

Recent A256940 News & Updates

No updates

Keeps Biopharma Inc. Key Details

₩136.5b

Revenue

₩116.3b

Cost of Revenue

₩20.2b

Gross Profit

₩27.5b

Other Expenses

-₩7.3b

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-382.05
Gross Margin
14.80%
Net Profit Margin
-5.34%
Debt/Equity Ratio
88.9%

Keeps Biopharma Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About A256940

Founded
2000
Employees
28
CEO
Young Kim Ha
WebsiteView website
www.kpscorp.co.kr

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

South Korean Market Performance

  • 7 Days: -1.6%
  • 3 Months: 21.9%
  • 1 Year: 21.3%
  • Year to Date: 30.7%
Over the last 7 days, the market has dropped 1.6%, driven by a decline of 3.6% in the Information Technology sector. In the last year, the market is actually up 21%. As for the next few years, earnings are expected to grow by 22% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading